As of 6:30pm ET
| -0.06 / -0.88%|
The 3 analysts offering 12-month price forecasts for American Renal Associates Holdings Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +4.01% increase from the last price of 6.73.
The current consensus among 3 polled investment analysts is to Hold stock in American Renal Associates Holdings Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.